D. Wilkins

发表

Correlating the degree of needle trauma during prostate brachytherapy and the development of acute urinary toxicity.

J. Cygler, L. Eapen, C. Kayser, 2004, International journal of radiation oncology, biology, physics.

Evaluation of cisplatin response in three radiation resistant and three radiation sensitive cell lines.

D. Wilkins, C. Ng, G. Raaphorst, 1994, Anticancer research.

A study of prostate delineation referenced against a gold standard created from the visible human data.

David Wilkins, L. Eapen, C. Morash, 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiobiological parameters suitable for modeling individual outcomes cannot be obtained by analyzing heterogeneous population data with homogeneous tumor control model: in regard to D'Souza et al. (Int J Radiat Oncol Biol Phys 2004;58:1540-1548).

D. Wilkins, G. Raaphorst, M. Carlone, 2005, International journal of radiation oncology, biology, physics.

Cisplatin and low dose rate irradiation in cisplatin resistant and sensitive human glioma cells.

D. Wilkins, C. Ng, G. Raaphorst, 1996, International journal of radiation oncology, biology, physics.

TCP isoeffect analysis using a heterogeneous distribution of radiosensitivity.

David Wilkins, Marco Carlone, D. Wilkins, 2004, Medical physics.

Correlation between Gd-enhanced MR imaging and histopathology in treated and untreated 9L rat brain tumors.

G. Sutherland, D. Wilkins, J. Saunders, 1995, Magnetic resonance imaging.

Effect of hyperthermia on cisplatin sensitivity in human glioma and ovarian carcinoma cell lines resistant and sensitive to cisplatin treatment.

D. Wilkins, C. Ng, G. Raaphorst, 1996, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Evaluation of cross-resistance between responses to cisplatin, hyperthermia, and radiation in human glioma cells and eight clones selected for cisplatin resistance.

D. Wilkins, C. Ng, J. Mao, 1999, Radiation oncology investigations.

l Biology Original Contribution CISPLATIN AND LOW DOSE RATE IRRADIATION IN CISPLATIN RESISTANT AND SENSITIVE HUMAN GLIOMA CELLS

D. Wilkins, C. Ng, G. Raaphorst, 1996 .

Cell cycle perturbations in cisplatin-sensitive and resistant human ovarian carcinoma cells following treatment with cisplatin and low dose rate irradiation

D. Wilkins, C. Ng, G. Raaphorst, 1997, Cancer Chemotherapy and Pharmacology.

Comparison of alpha/beta estimates from homogeneous (individual) and heterogeneous (population) tumor control models for early stage prostate cancer.

D. Wilkins, M. Carlone, B. Nyiri, 2003, Medical physics.

Fitting the linear–quadratic model to detailed data sets for different dose ranges

D. Wilkins, G. Raaphorst, L. Garcia, 2006, Physics in medicine and biology.

Junctioning longitudinally adjacent PTVs with Helical TomoTherapy

D. Wilkins, L. Gerig, P. Raaphorst, 2010, Journal of applied clinical medical physics.

α/β ratio: A dose range dependence study

D. Wilkins, G. Raaphorst, L. Garcia, 2007 .

Alpha/beta ratio: A dose range dependence study.

D. Wilkins, G. Raaphorst, L. M. Garcia, 2007, International journal of radiation oncology, biology, physics.

Cisplatin, hyperthermia and radiation treatment in human cisplatin-sensitive and resistant glioma cell lines.

D. Wilkins, C. Ng, G. Raaphorst, 1996, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Comparison of α/β estimates from homogeneous (individual) and heterogeneous (population) tumor control models for early stage prostate cancer

D. Wilkins, M. Carlone, B. Nyiri, 2003 .

Inhibition of potentially lethal damage recovery by cisplatin in a brain tumor cell line.

D. Wilkins, G. Raaphorst, D. Heller, 1993, Anticancer research.